Safety and biological outcomes following a phase 1 trial of GD2-specific CAR-T cells in patients with GD2-positive metastatic melanoma and other solid cancers - Concepedia

Concepedia

Publication | Open Access

Safety and biological outcomes following a phase 1 trial of GD2-specific CAR-T cells in patients with GD2-positive metastatic melanoma and other solid cancers

DOI Full Paper Access

46

Citations

40

References

2024

Year

Tessa Gargett, Nga Truong, Bryan Gardam, Wenbo Yu, Lisa M. Ebert, Amy W. Johnson, Erica C. F. Yeo, Nicole L. Wittwer, Gonzalo Tapia Rico, Jesikah Logan,

Journal for ImmunoTherapy of Cancer

Abstract

ACTRN12613000198729.

References

	Year	Citations

Page 1